Linezolid is effective against multidrug-resistant TB (MDR-TB) but is frequently associated with adverse events that limit long-term use. However, data on the clinical outcomes following linezolid-related adverse events among patients with MDR-TB remain limited.This retrospective multicentre study in Japan comprised 81 patients with MDR-TB who developed linezolid-related adverse events during treatment with an initial standard dose...
Int J Tuberc Lung Dis. 2025 Sep 26;29(10):462-468. doi: 10.5588/ijtld.25.0125.
ABSTRACT
.
PMID:41410988 | DOI:10.5588/ijtld.25.0125